Related Experiment Videos
Chlamydial infections (second of three parts)
The New England Journal of Medicine
|March 2, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Extracellular ATP hydrolysis in Caco-2 human intestinal cell line.
Biochimica et biophysica acta. Biomembranes·2021
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.
The New England journal of medicine·2026
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine·2026
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.
The New England journal of medicine·2026